药品注册申请号:014901
申请类型:NDA (新药申请)
申请人:APOTHECON
申请人全名:APOTHECON INC DIV BRISTOL MYERS SQUIBB
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 KENALOG-40 TRIAMCINOLONE ACETONIDE INJECTABLE;INJECTION 40MG/ML Yes Yes AB 1965/02/01 Approved Prior to Jan 1, 1982 Prescription
002 KENALOG-80 TRIAMCINOLONE ACETONIDE INJECTABLE;INJECTION 80MG/ML Yes Yes None 2019/04/12 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2019/04/12 SUPPL-47(补充) Approval Manufacturing (CMC) STANDARD
2018/06/22 SUPPL-45(补充) Approval Labeling STANDARD
2018/03/29 SUPPL-44(补充) Approval Labeling STANDARD
2015/10/26 SUPPL-43(补充) Approval Manufacturing (CMC) STANDARD
2014/07/03 SUPPL-42(补充) Approval Labeling STANDARD
2011/07/15 SUPPL-39(补充) Approval Labeling UNKNOWN
2011/06/16 SUPPL-38(补充) Approval Labeling UNKNOWN
2010/01/28 SUPPL-37(补充) Approval Labeling STANDARD
2006/11/20 SUPPL-34(补充) Approval Labeling STANDARD
2001/01/05 SUPPL-35(补充) Approval Manufacturing (CMC) STANDARD
1996/05/22 SUPPL-33(补充) Approval Manufacturing (CMC) STANDARD
1995/01/10 SUPPL-31(补充) Approval Manufacturing (CMC) STANDARD
1994/03/28 SUPPL-30(补充) Approval Manufacturing (CMC) STANDARD
1992/02/14 SUPPL-28(补充) Approval Manufacturing (CMC) STANDARD
1991/07/19 SUPPL-29(补充) Approval Manufacturing (CMC) STANDARD
1987/11/30 SUPPL-26(补充) Approval Manufacturing (CMC) STANDARD
1986/11/19 SUPPL-27(补充) Approval Manufacturing (CMC) STANDARD
1985/12/04 SUPPL-22(补充) Approval Manufacturing (CMC) STANDARD
1985/06/14 SUPPL-25(补充) Approval Labeling
1984/04/13 SUPPL-24(补充) Approval Manufacturing (CMC) STANDARD
1982/06/30 SUPPL-21(补充) Approval Manufacturing (CMC) STANDARD
1980/05/20 SUPPL-18(补充) Approval Manufacturing (CMC) STANDARD
1979/08/21 SUPPL-19(补充) Approval Manufacturing (CMC) STANDARD
1979/07/27 SUPPL-9(补充) Approval Labeling
1979/07/17 SUPPL-17(补充) Approval Manufacturing (CMC) STANDARD
1978/04/07 SUPPL-16(补充) Approval Manufacturing (CMC) STANDARD
1978/04/07 SUPPL-10(补充) Approval Labeling
1965/02/01 ORIG-1(原始申请) Approval Type 5 - New Formulation or New Manufacturer STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:TRIAMCINOLONE ACETONIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:40MG/ML 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
014901 001 NDA KENALOG-40 TRIAMCINOLONE ACETONIDE INJECTABLE;INJECTION 40MG/ML Prescription Yes Yes AB Approved Prior to Jan 1, 1982 APOTHECON
207550 001 ANDA TRIAMCINOLONE ACETONIDE TRIAMCINOLONE ACETONIDE INJECTABLE;INJECTION 40MG/ML Prescription No No AB 2017/12/11 AMNEAL
209852 001 ANDA TRIAMCINOLONE ACETONIDE TRIAMCINOLONE ACETONIDE INJECTABLE;INJECTION 40MG/ML Prescription No No AB 2018/10/05 TEVA PHARMS USA
213543 001 ANDA TRIAMCINOLONE ACETONIDE TRIAMCINOLONE ACETONIDE INJECTABLE;INJECTION 40MG/ML Prescription No No AB 2022/01/19 LONG GROVE PHARMS
212400 001 ANDA TRIAMCINOLONE ACETONIDE TRIAMCINOLONE ACETONIDE INJECTABLE;INJECTION 40MG/ML Prescription No No AB 2022/07/05 EUGIA PHARMA
212567 001 ANDA TRIAMCINOLONE ACETONIDE TRIAMCINOLONE ACETONIDE INJECTABLE;INJECTION 40MG/ML Prescription No No AB 2022/11/02 MYLAN LABS LTD
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database